Literature DB >> 7572319

A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats.

H Qi1, M Li, T J Wronski.   

Abstract

Previous studies have shown that parathyroid hormone (PTH) stimulates bone formation and completely restores lost cancellous bone at skeletal sites with moderate osteopenia in relatively young ovariectomized (OVX) rats. The current study was designed to determine whether PTH has similar bone anabolic effects in aged OVX rats and to compare the bone restorative response to PTH at skeletal sites with moderate and severe osteopenia. Female Sprague-Dawley rats were subjected to sham surgery or bilateral ovariectomy at 3 months of age and maintained untreated for the first year after surgery to allow for the development of moderate vertebral osteopenia and severe tibial osteopenia in OVX rats. Groups of baseline control and OVX rats were sacrificed at the end of this pretreatment period. The remaining OVX rats were then treated for 10 weeks with vehicle, antiresorptive agents alone (estrogen, the bisphosphonate risedronate, or calcitonin) or PTH alone. Other groups of OVX rats were treated concurrently with PTH and each of the antiresorptive agents. As expected, the proximal tibia of baseline OVX rats exhibited severe cancellous osteopenia, whereas the first lumbar vertebral body was moderately osteopenic. Treatment of OVX rats with antiresorptive agents alone failed to restore cancellous bone at both skeletal sites, whereas treatment with PTH alone markedly stimulated bone formation and completely restored lost cancellous bone in the lumbar vertebra. PTH also stimulated bone formation and in the severely osteopenic proximal tibia of OVX rats but only marginally restored lost cancellous bone, possibly due to an inadequate number of bone spicules to serve as a foundation for new bone formation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7572319     DOI: 10.1002/jbmr.5650100616

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  12 in total

1.  CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.

Authors:  Fei Liu; Sun-Kyeong Lee; Douglas J Adams; Gloria A Gronowicz; Barbara E Kream
Journal:  Bone       Date:  2007-02-01       Impact factor: 4.398

2.  Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats.

Authors:  Wei Yao; Tamer Hadi; Yebin Jiang; Jeff Lotz; Thomas J Wronski; Nancy E Lane
Journal:  Osteoporos Int       Date:  2005-08-05       Impact factor: 4.507

3.  Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain.

Authors:  K C Westerlind; T J Wronski; E L Ritman; Z P Luo; K N An; N H Bell; R T Turner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Comparison of treatment effects of teriparatide and the bisphosphonate risedronate in an aged, osteopenic, ovariectomized rat model under various clinical conditions.

Authors:  Ayano Sugie-Oya; Aya Takakura; Ryoko Takao-Kawabata; Hiroko Sano; Yukari Shimazu; Yukihiro Isogai; Akira Yamaguchi; Toshinori Ishizuya
Journal:  J Bone Miner Metab       Date:  2015-06-24       Impact factor: 2.626

5.  A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats.

Authors:  U T Iwaniec; K Moore; M F Rivera; S E Myers; S M Vanegas; T J Wronski
Journal:  Osteoporos Int       Date:  2006-11-22       Impact factor: 4.507

6.  Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen.

Authors:  W Zhao; M H Byrne; Y Wang; S M Krane
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

Review 7.  Nonproliferative and Proliferative Lesions of the Rat and Mouse Skeletal Tissues (Bones, Joints, and Teeth).

Authors:  Stacey Fossey; John Vahle; Philip Long; Scott Schelling; Heinrich Ernst; Rogely Waite Boyce; Jacquelin Jolette; Brad Bolon; Alison Bendele; Matthias Rinke; Laura Healy; Wanda High; Daniel Robert Roth; Michael Boyle; Joel Leininger
Journal:  J Toxicol Pathol       Date:  2016-07-29       Impact factor: 1.628

8.  In vitro and in vivo evidence for stimulation of bone resorption by an EP4 receptor agonist and basic fibroblast growth factor: Implications for their efficacy as bone anabolic agents.

Authors:  M E Downey; L S Holliday; J I Aguirre; T J Wronski
Journal:  Bone       Date:  2008-10-25       Impact factor: 4.398

9.  Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats.

Authors:  H B Jia; J X Ma; X L Ma; J T Yu; R Feng; L Y Xu; J Wang; D Xing; S W Zhu; Y Wang
Journal:  Osteoporos Int       Date:  2014-07-30       Impact factor: 4.507

10.  Transcriptional regulation of BMP2 expression by the PTH-CREB signaling pathway in osteoblasts.

Authors:  Rongrong Zhang; James R Edwards; Seon-Yle Ko; Shanshan Dong; Hongbin Liu; Babatunde O Oyajobi; Christopher Papasian; Hong-Wen Deng; Ming Zhao
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.